Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Moody's
MCO
5
Jefferies Financial
JEF
CA Stock MarketDetailed Quotes
EPRX Eupraxia Pharmaceuticals Inc
- 5.510
- +0.010+0.18%
15min DelayMarket Closed May 2 16:00 ET
197.53MMarket Cap-5.04P/E (TTM)
5.550High5.480Low11.31KVolume5.520Open5.500Pre Close62.33KTurnover6.49052wk High0.05%Turnover Ratio35.85MShares3.07052wk Low-1.093EPS TTM137.29MFloat Cap9.100Historical HighLossP/E (Static)24.92MShs Float0.800Historical Low-1.093EPS LYR1.27%Amplitude--Dividend TTM84.77P/B1Lot Size--Div YieldTTM
Eupraxia Pharmaceuticals Inc News
Eupraxia Pharmaceuticals Inc. to Present at Multiple Upcoming Investor and Scientific Conferences in April and May 2025
Eupraxia Pharmaceuticals Inc: MDA EN
Eupraxia Pharmaceuticals Inc: AUDITED ANNUAL FINANCIAL STATEMENTS EN
Eupraxia Pharmaceuticals Reports Fourth Quarter 2024 Financial Results
Eupraxia Surges 15% in U.S. Pre-market Trading After Reporting Positive Data From Resolve Phase 1b/2a Trial
Press Release: Eupraxia Pharmaceuticals Announces CFO Succession
Eupraxia Pharmaceuticals Up 5.5% In US Premarket As Says DiffuSphere Technology Demonstrates Targeted Drug Release
Eupraxia's DiffuSphere Technology Demonstrates Targeted Drug Release While Minimizing Systemic Exposure for a Period of More Than Six Months
Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting
Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Eosinophilic Esophagitis: The Emerging Digestive Disorder Frequently Misdiagnosed", on November 15, 2024
Express News | Eupraxia Pharmaceuticals Inc : Raymond James Cuts Target Price to $12 From $16.50
MT Newswires Stocks To Watch: Eupraxia Pharmaceuticals and I-80 Gold. Also Conifex, Crown; Dream Unlimited; DCM; NGEx; Peyto; Primaris REIT; VIQ Solutions
Eupraxia Pharmaceuticals Inc: INTERIM MDA EN
Eupraxia Pharmaceuticals Inc: INTERIM FINANCIAL STATEMENTSREPORT EN
Press Release: Eupraxia Pharmaceuticals Reports Third Quarter 2024 Financial Results
MT Newswires Canada Stocks To Watch: Cogecos; Black Diamond; Brookfield Asset Management and Brookfield Corp; Eupraxia
Lancet Rheumatology Publishes Phase 2b Data on Eupraxia Pharmaceuticals' EP-104IAR
Eupraxia Pharmaceuticals Details Executive Appointments
Eupraxia Pharmaceuticals Brief: Appointing Chief Scientific Officer Amanda Malone, as Chief Operating and Scientific Officer, and Rahul Sarugaser, as Executive Vice President of Corporate Development
Eupraxia Pharmaceuticals Reports Positive Data From RESOLVE Trial
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts